Paul Colville‐Nash

5.9k total citations · 2 hit papers
52 papers, 5.0k citations indexed

About

Paul Colville‐Nash is a scholar working on Pharmacology, Molecular Biology and Rheumatology. According to data from OpenAlex, Paul Colville‐Nash has authored 52 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 21 papers in Molecular Biology and 9 papers in Rheumatology. Recurrent topics in Paul Colville‐Nash's work include Inflammatory mediators and NSAID effects (23 papers), Cell Adhesion Molecules Research (9 papers) and Eicosanoids and Hypertension Pharmacology (8 papers). Paul Colville‐Nash is often cited by papers focused on Inflammatory mediators and NSAID effects (23 papers), Cell Adhesion Molecules Research (9 papers) and Eicosanoids and Hypertension Pharmacology (8 papers). Paul Colville‐Nash collaborates with scholars based in United Kingdom, United States and Ireland. Paul Colville‐Nash's co-authors include D. A. Willoughby, Derek W. Gilroy, Dean Willis, Toby Lawrence, Mark J. Paul‐Clark, Joanna E. Chivers, Adrian Moore, D L Scott, Justine Newson and Melanie Stables and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Medicine.

In The Last Decade

Paul Colville‐Nash

52 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inducible cyclooxygenase may have anti-inflammatory properties

1999 1.1k citations Derek W. Gilroy, Paul Colville‐Nash et al. Nature Medicine profile →
Possible new role for NF-κB in the resolution of inflammation

2001 643 citations Toby Lawrence, Derek W. Gilroy et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Colville‐Nash United Kingdom	30	1.9k	1.5k	1.2k	684	668	52	5.0k
Mark J. Paul‐Clark United Kingdom	30	1.5k 0.8×	788 0.5×	1.1k 0.9×	457 0.7×	362 0.5×	50	3.5k
Karin Müller‐Decker Germany	38	2.0k 1.0×	912 0.6×	537 0.4×	291 0.4×	831 1.2×	87	4.6k
Pierre Borgeat Canada	40	1.5k 0.8×	1.0k 0.7×	1.5k 1.3×	772 1.1×	201 0.3×	108	5.1k
Scott D. Hauser United States	20	2.5k 1.3×	3.0k 2.0×	629 0.5×	774 1.1×	1000 1.5×	24	6.9k
Goo Taeg Oh South Korea	45	3.3k 1.7×	744 0.5×	1.3k 1.0×	235 0.3×	640 1.0×	175	6.9k
Mark J. Czaja United States	49	2.9k 1.5×	413 0.3×	808 0.7×	683 1.0×	677 1.0×	90	8.0k
Ákos Heinemann Austria	54	1.8k 0.9×	1.4k 0.9×	1.7k 1.4×	472 0.7×	376 0.6×	214	7.2k
Ashok R. Amin United States	26	1.1k 0.6×	1.2k 0.8×	739 0.6×	296 0.4×	390 0.6×	56	4.0k
Won‐Il Jeong South Korea	37	1.7k 0.9×	620 0.4×	1.2k 1.0×	241 0.4×	490 0.7×	92	6.0k
G.A. Higgs United Kingdom	31	877 0.5×	1.6k 1.1×	698 0.6×	583 0.9×	208 0.3×	58	4.0k

Countries citing papers authored by Paul Colville‐Nash

Since Specialization

Citations

This map shows the geographic impact of Paul Colville‐Nash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Colville‐Nash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Colville‐Nash more than expected).

Fields of papers citing papers by Paul Colville‐Nash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Colville‐Nash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Colville‐Nash. The network helps show where Paul Colville‐Nash may publish in the future.

Co-authorship network of co-authors of Paul Colville‐Nash

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Colville‐Nash. A scholar is included among the top collaborators of Paul Colville‐Nash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Colville‐Nash. Paul Colville‐Nash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Byström, Jonas, Ian Evans, Justine Newson, et al.. (2008). Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood. 112(10). 4117–4127. 259 indexed citations

Colville‐Nash, Paul, et al.. (2008). Albumin induces interleukin-6 release from primary human proximal tubule epithelial cells. Journal of Nephrology. 21(6). 887–893. 13 indexed citations

Phanish, Mysore K., et al.. (2007). The TGFβ1-Induced Fibronectin in Human Renal Proximal Tubular Epithelial Cells Is p38 MAP Kinase Dependent and Smad Independent. Nephron Experimental Nephrology. 105(4). e108–e116. 24 indexed citations

Trivedi, Seema, Justine Newson, Ravindra Rajakariar, et al.. (2006). Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity. Proceedings of the National Academy of Sciences. 103(13). 5179–5184. 109 indexed citations

Sawatzky, Deborah A., D. A. Willoughby, Paul Colville‐Nash, & Adriano G. Rossi. (2006). The Involvement of the Apoptosis-Modulating Proteins ERK 1/2, Bcl-xL and Bax in the Resolution of Acute Inflammation in Vivo. American Journal Of Pathology. 168(1). 33–41. 102 indexed citations

Ayoub, Samir S., Paul Colville‐Nash, D. A. Willoughby, & Regina M. Botting. (2006). The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice. European Journal of Pharmacology. 538(1-3). 57–65. 61 indexed citations

Colville‐Nash, Paul, et al.. (2005). The peroxisome proliferator-activated receptor α activator, Wy14,643, is anti-inflammatory in vivo. Inflammopharmacology. 12(5-6). 493–504. 13 indexed citations

Seed, Michael, Judith C. Brown, Mauro Perretti, et al.. (2005). The inhibition of neutrophil-endothelial cell adhesion by hyaluronan independent of CD44. Inflammopharmacology. 12(5-6). 535–550. 13 indexed citations

Colville‐Nash, Paul, Derek W. Gilroy, Dean Willis, et al.. (2005). Prostaglandin F2α produced by inducible cyclooxygenase may contribute to the resolution of inflammation. Inflammopharmacology. 12(5-6). 473–476. 13 indexed citations

10.

Lawrence, Toby, Derek W. Gilroy, Paul Colville‐Nash, & D. A. Willoughby. (2001). Possible new role for NF-κB in the resolution of inflammation. Nature Medicine. 7(12). 1291–1297. 643 indexed citations breakdown →

11.

Gilroy, Derek W. & Paul Colville‐Nash. (2000). New insights into the role of COX 2 in inflammation. Journal of Molecular Medicine. 78(3). 121–129. 109 indexed citations

12.

Willoughby, D. A., Adrian Moore, & Paul Colville‐Nash. (2000). Cyclopentenone prostaglandins—new allies in the war on inflammation. Nature Medicine. 6(2). 137–138. 47 indexed citations

13.

Willoughby, D. A., Adrian Moore, & Paul Colville‐Nash. (2000). COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. The Lancet. 355(9204). 646–648. 245 indexed citations

14.

Gilroy, Derek W., Paul Colville‐Nash, Dean Willis, et al.. (1999). Inducible cyclooxygenase may have anti-inflammatory properties. Nature Medicine. 5(6). 698–701. 1069 indexed citations breakdown →

15.

Moore, A. R., et al.. (1999). Effects of hyaluronan on models of immediate and delayed hypersensitivity in the rat. International Journal of Immunopharmacology. 21(3). 195–203. 3 indexed citations

16.

Appleton, Ian, Nicola J. Brown, Dean Willis, et al.. (1996). THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN A MURINE CHRONIC GRANULOMATOUS TISSUE AIR POUCH MODEL OF ANGIOGENESIS. The Journal of Pathology. 180(1). 90–94. 45 indexed citations

17.

Colville‐Nash, Paul, Mona A. El‐Ghazaly, & D. A. Willoughby. (1993). The use of angiostatic steroids to inhibit cartilage destruction in anin vivo model of granuloma-mediated cartilage degradation. Inflammation Research. 38(S1). 126–134. 14 indexed citations

18.

Silva, José António Pereira da, Paul Colville‐Nash, Tim D. Spector, David L. Scott, & D. A. Willoughby. (1993). Inflammation‐induced cartilage degradation in female rodents. protective role of sex hormones. Arthritis & Rheumatism. 36(7). 1007–1013. 34 indexed citations

19.

Appleton, Ian, Anneka Tomlinson, Paul Colville‐Nash, & D. A. Willoughby. (1993). Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair processes.. PubMed. 69(4). 405–14. 75 indexed citations

20.

Chander, C. L., D. Howat, Adrian Moore, et al.. (1990). Comparison of endothelin-1 and-3 on models of inflammation. Inflammation Research. 29(1-2). 27–29. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact